HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna R Cliffe Selected Research

Etoposide (VP 16)

2/2010Herpes simplex virus VP16, but not ICP0, is required to reduce histone occupancy and enhance histone acetylation on viral genomes in U2OS osteosarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna R Cliffe Research Topics

Disease

8Latent Infection
02/2024 - 08/2009
7Infections
02/2024 - 12/2008
1COVID-19
01/2024
1Superinfection
01/2022
1Coinfection
01/2022
1Herpes Simplex
01/2013
1Virus Diseases (Viral Diseases)
02/2010
1Osteosarcoma (Osteogenic Sarcoma)
02/2010

Drug/Important Bio-Agent (IBA)

5Histones (Histone)IBA
02/2024 - 12/2008
4HeterochromatinIBA
02/2024 - 01/2013
4ChromatinIBA
01/2013 - 12/2008
3Lysine (L-Lysine)FDA Link
02/2024 - 01/2013
3Viral DNAIBA
01/2022 - 12/2008
2Trans-Activators (Trans-Acting Factor)IBA
02/2024 - 11/2023
1VaccinesIBA
01/2024
1MicroRNAs (MicroRNA)IBA
09/2023
1Messenger RNA (mRNA)IBA
09/2023
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2022
1Interferon Type IIBA
01/2021
1CytokinesIBA
01/2021
1Polycomb-Group ProteinsIBA
01/2013
1Etoposide (VP 16)FDA LinkGeneric
02/2010
1Antiviral Agents (Antivirals)IBA
02/2010
1DNA (Deoxyribonucleic Acid)IBA
12/2008